Cargando…

Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease

BACKGROUND: Pompe disease is an autosomal recessive metabolic disorder caused by the deficiency of the lysosomal enzyme acid α-glucosidase. This deficiency leads to glycogen accumulation in the lysosomes of muscle tissue causing progressive muscular weakness particularly of the respiratory system. E...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitja, Jevnikar, Metka, Kodric, Fabiana, Cantarutti, Cifaldi, Rossella, Longo, Cinzia, Rossana, Della Porta, Bruno, Bembi, Marco, Confalonieri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471388/
https://www.ncbi.nlm.nih.gov/pubmed/28649546
http://dx.doi.org/10.1016/j.ymgmr.2015.09.007
_version_ 1783243940186554368
author Mitja, Jevnikar
Metka, Kodric
Fabiana, Cantarutti
Cifaldi, Rossella
Longo, Cinzia
Rossana, Della Porta
Bruno, Bembi
Marco, Confalonieri
author_facet Mitja, Jevnikar
Metka, Kodric
Fabiana, Cantarutti
Cifaldi, Rossella
Longo, Cinzia
Rossana, Della Porta
Bruno, Bembi
Marco, Confalonieri
author_sort Mitja, Jevnikar
collection PubMed
description BACKGROUND: Pompe disease is an autosomal recessive metabolic disorder caused by the deficiency of the lysosomal enzyme acid α-glucosidase. This deficiency leads to glycogen accumulation in the lysosomes of muscle tissue causing progressive muscular weakness particularly of the respiratory system. Enzyme replacement therapy (ERT) has demonstrated efficacy in slowing down disease progression in infants. Despite the large number of studies describing the effects of physical training in juvenile and adult late onset Pompe disease (LOPD). There are very few reports that analyze the benefits of respiratory muscle rehabilitation or training. METHODS: The effectiveness of respiratory muscle training was investigated using a specific appliance with adjustable resistance (Threshold). The primary endpoint was effect on respiratory muscular strength by measurements of MIP and MEP. Eight late-onset Pompe patients (aged 13 to 58 years; 4 female, 4 male) with respiratory muscle deficiency on functional respiratory tests were studied. All patients received ERT at the dosage of 20 mg/kg/every 2 weeks and underwent training with Threshold at specified pressures for 24 months. RESULTS: A significant increase in MIP was observed during the follow-up of 24 month: 39.6 cm H(2)O (+ 25.0%) at month 3; 39.5 cm H(2)O (+ 24.9%) at month 6; 39.1 cm H(2)O (+ 23.7%) at month 9; 37.3 cm H(2)O (+ 18.2%) at month 12; and 37.3 cm H(2)O (+ 17.8%) at month 24. Median MEP values also showed a significant increase during the first 9 months: 29.8 cm H(2)O, (+ 14.3%) at month 3; 31.0 cm H(2)O (+ 18.6) at month 6; and 29.5 cm H(2)O (+ 12.9) at month 9. MEP was then shown to be decreased at months 12 and 24; median MEP was 27.2 cm H(2)O (+ 4.3%) at 12 months and 26.6 cm H(2)O (+ 1.9%) at 24 months. The FVC remain stable throughout the study. CONCLUSION: An increase in respiratory muscular strength was demonstrated with Threshold training when used in combination with ERT.
format Online
Article
Text
id pubmed-5471388
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-54713882017-06-23 Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease Mitja, Jevnikar Metka, Kodric Fabiana, Cantarutti Cifaldi, Rossella Longo, Cinzia Rossana, Della Porta Bruno, Bembi Marco, Confalonieri Mol Genet Metab Rep Research Paper BACKGROUND: Pompe disease is an autosomal recessive metabolic disorder caused by the deficiency of the lysosomal enzyme acid α-glucosidase. This deficiency leads to glycogen accumulation in the lysosomes of muscle tissue causing progressive muscular weakness particularly of the respiratory system. Enzyme replacement therapy (ERT) has demonstrated efficacy in slowing down disease progression in infants. Despite the large number of studies describing the effects of physical training in juvenile and adult late onset Pompe disease (LOPD). There are very few reports that analyze the benefits of respiratory muscle rehabilitation or training. METHODS: The effectiveness of respiratory muscle training was investigated using a specific appliance with adjustable resistance (Threshold). The primary endpoint was effect on respiratory muscular strength by measurements of MIP and MEP. Eight late-onset Pompe patients (aged 13 to 58 years; 4 female, 4 male) with respiratory muscle deficiency on functional respiratory tests were studied. All patients received ERT at the dosage of 20 mg/kg/every 2 weeks and underwent training with Threshold at specified pressures for 24 months. RESULTS: A significant increase in MIP was observed during the follow-up of 24 month: 39.6 cm H(2)O (+ 25.0%) at month 3; 39.5 cm H(2)O (+ 24.9%) at month 6; 39.1 cm H(2)O (+ 23.7%) at month 9; 37.3 cm H(2)O (+ 18.2%) at month 12; and 37.3 cm H(2)O (+ 17.8%) at month 24. Median MEP values also showed a significant increase during the first 9 months: 29.8 cm H(2)O, (+ 14.3%) at month 3; 31.0 cm H(2)O (+ 18.6) at month 6; and 29.5 cm H(2)O (+ 12.9) at month 9. MEP was then shown to be decreased at months 12 and 24; median MEP was 27.2 cm H(2)O (+ 4.3%) at 12 months and 26.6 cm H(2)O (+ 1.9%) at 24 months. The FVC remain stable throughout the study. CONCLUSION: An increase in respiratory muscular strength was demonstrated with Threshold training when used in combination with ERT. Elsevier 2015-10-29 /pmc/articles/PMC5471388/ /pubmed/28649546 http://dx.doi.org/10.1016/j.ymgmr.2015.09.007 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Mitja, Jevnikar
Metka, Kodric
Fabiana, Cantarutti
Cifaldi, Rossella
Longo, Cinzia
Rossana, Della Porta
Bruno, Bembi
Marco, Confalonieri
Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease
title Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease
title_full Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease
title_fullStr Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease
title_full_unstemmed Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease
title_short Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease
title_sort respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset pompe disease
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471388/
https://www.ncbi.nlm.nih.gov/pubmed/28649546
http://dx.doi.org/10.1016/j.ymgmr.2015.09.007
work_keys_str_mv AT mitjajevnikar respiratorymuscletrainingwithenzymereplacementtherapyimprovesmusclestrengthinlateonsetpompedisease
AT metkakodric respiratorymuscletrainingwithenzymereplacementtherapyimprovesmusclestrengthinlateonsetpompedisease
AT fabianacantarutti respiratorymuscletrainingwithenzymereplacementtherapyimprovesmusclestrengthinlateonsetpompedisease
AT cifaldirossella respiratorymuscletrainingwithenzymereplacementtherapyimprovesmusclestrengthinlateonsetpompedisease
AT longocinzia respiratorymuscletrainingwithenzymereplacementtherapyimprovesmusclestrengthinlateonsetpompedisease
AT rossanadellaporta respiratorymuscletrainingwithenzymereplacementtherapyimprovesmusclestrengthinlateonsetpompedisease
AT brunobembi respiratorymuscletrainingwithenzymereplacementtherapyimprovesmusclestrengthinlateonsetpompedisease
AT marcoconfalonieri respiratorymuscletrainingwithenzymereplacementtherapyimprovesmusclestrengthinlateonsetpompedisease